SCHEMBL2582409

SCHEMBL2582409

c1ccc(CC2(Cc3ccccc3)COCCOCCCOCCOC2)cc1

nearest known ligand 0.42

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MAOA P21397 4/20 0.38
MAOB P27338 4/20 0.38
FKBP1A P62942 1/20 0.36
POLB P06746 1/20 0.35
SIGMAR1 Q99720 1/20 0.35
LMNA P02545 4/20 0.34
MEN1 O00255 2/20 0.34
KMT2A Q03164 2/20 0.34
NPSR1 Q6W5P4 1/20 0.34
OPRM1 P35372 1/20 0.34
OPRL1 P41146 1/20 0.34
GAA P10253 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
CRHBP P24387 2/20 0.33
CRHR2 Q13324 2/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
HTT P42858 1/20 0.33
KDM1A O60341 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28293435 0.81 MAOA (0.45) MAOAMAOBPOLBLMNAMEN1
SCHEMBL706405 0.81 MAOA (0.35) MAOAMAOBFKBP1APOLBSIGMAR1
SCHEMBL8019177 0.80 MAOA (0.34) MAOAMAOBFKBP1APOLBSIGMAR1
SCHEMBL29017327 0.75 GAA (0.43) MAOAMAOBPOLBLMNAMEN1
SCHEMBL29017486 0.75 GAA (0.43) MAOAMAOBPOLBLMNAMEN1
SCHEMBL29228003 0.75 MAOA (0.42) MAOAMAOBMEN1KMT2AOPRM1
SCHEMBL1007966 0.74 MAOA (0.38) MAOAMAOBFKBP1APOLBSIGMAR1
SCHEMBL1009359 0.74 MAOA (0.38) MAOAMAOBFKBP1APOLBSIGMAR1
SCHEMBL1009707 0.74 MAOA (0.38) MAOAMAOBFKBP1APOLBSIGMAR1
SCHEMBL3906018 0.74 MAOA (0.39) MAOAMAOBFKBP1APOLBSIGMAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 58 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025120574-A1 SELECTIVE MEMBRANE SYSTEM AND METHOD FOR DESALINATION AND MINERAL RECOVERY NEOM COMPANY (SA) 2025-06-12 WO claimed
CN-111821869-A Lithium ion selective membrane and preparation method thereof 深圳市锦瑞生物科技有限公司 2020-10-27 CN claimed
US-6508921-B1 Depresses sodium interference; membrane has 6,6-dibenzyl-1,4,8,11 tetraoxacyclotetradecane ionophore; potassium tetrakis(4-chlorophenyl)borate; plasticizer is mixture of 2-Nitrophenyloctyl ether and trioctylphosphate; quantitative BECKMAN COULTER, INC. 2003-01-21 US claimed
EP-4673239-A2 HYDROPHOBIC ORGANIC LIQUID COMPOSITION FOR THE SELECTIVE EXTRACTION OF A LITHIUM SALT Adionics (FR) 2026-01-07 EP disclosed
US-20250258105-A1 ION DETECTION WITHOUT OPTICAL INTERFERENCE FROM SAMPLES UNIV VIRGINIA COMMONWEALTH (US) 2025-08-14 US disclosed
WO-2025120574-A1 SELECTIVE MEMBRANE SYSTEM AND METHOD FOR DESALINATION AND MINERAL RECOVERY NEOM COMPANY (SA) 2025-06-12 WO disclosed
CN-116026908-B Method for voltammetric analysis of lithium ion concentration, electrode for lithium ion voltammetry analysis, method for producing electrode for lithium ion voltammetry analysis, and device for lithium ion voltammetry analysis 中南大学 2025-06-10 CN disclosed
EP-4531680-A1 SENSING SYSTEMS AND METHODS FOR DIAGNOSING KIDNEY DISEASE Dexcom, Inc. (US) 2025-04-09 EP disclosed
CN-119730782-A Apparatus and method for measuring concentration of target analyte in biological fluid in vivo 德克斯康公司 2025-03-28 CN disclosed
EP-4511650-A1 ION DETECTION WITHOUT OPTICAL INTERFERENCE FROM SAMPLES Virginia Commonwealth University (US) 2025-02-26 EP disclosed
US-20240366627-A1 SMALL MOLECULES FOR MOUSE SATELLITE CELL PROLIFERATION PRESIDENT AND FELLOWS OF HARVARD COLLEGE 2024-11-07 US disclosed
EP-1271143-A1 SPECIMEN HAVING CAPABILITY OF SEPARATING SOLID COMPONENT ARKRAY, Inc. (JP) 2003-01-02 EP disclosed
EP-1269174-A2 LITHIUM ION-SELECTIVE ELECTRODE FOR CLINICAL APPLICATIONS Beckman Coulter, Inc. (US) 2003-01-02 EP disclosed
WO-2001073425-A3 LITHIUM ION-SELECTIVE ELECTRODE FOR CLINICAL APPLICATIONS BECKMAN COULTER INC (US) 2002-07-04 WO disclosed
EP-0860695-A9 METHOD OF MEASUREMENT OF MATERIAL AND TESTPIECE KABUSHIKI KAISHA KYOTO DAIICHI KAGAKU (JP) 2001-10-17 EP disclosed
WO-2001073425-A2 LITHIUM ION-SELECTIVE ELECTRODE FOR CLINICAL APPLICATIONS BECKMAN COULTER, INC. (US) 2001-10-04 WO disclosed
WO-2001073425-A2 LITHIUM ION-SELECTIVE ELECTRODE FOR CLINICAL APPLICATIONS BECKMAN COULTER, INC. (US) 2001-10-04 WO disclosed
US-5911862-A LESS PLASTICIZER CHIRON DIAGNOSTICS CORPORATION (US) 1999-06-15 US disclosed
EP-0860695-A1 METHOD OF MEASUREMENT OF MATERIAL AND TESTPIECE KABUSHIKI KAISHA KYOTO DAIICHI KAGAKU (JP) 1998-08-26 EP disclosed
US-5738774-A ETHYENE-VINYL ACETATE COPOLYMER, A REDUCED AMOUNT OF PLASTICIZER AND AN ION SELECTIVE MATERIAL THE GOVERNORS OF THE UNIVERSITY OF ALBERTA (CA) 1998-04-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240366627-A1 SMALL MOLECULES FOR MOUSE SATELLITE CELL PROLIFERATION MKI67, MYLK2, MYH2 MAOA 4746/4885MAOB 4652/4885FKBP1A 2190/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.